ArticleTargeted oncology2026

Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin.

Wendy Stock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.